in Atlanta.
Financial Timetable
February 12, 2008 2007 results - Analyst/Investor meeting in Paris
April 30, 2008 2008 first-quarter net sales and results
May 14, 2008 Shareholders' Annual General Meeting
July 31, 2008 2008 second-quarter net sales and results
October 31, 2008 2008 third-quarter net sales and results
Appendices
List of appendices
Appendix 1: Explanatory Notes/Financial Indicators
Appendix 2: 2007 third-quarter, 9-month, first-quarter and second-quarter
net sales by product
Appendix 3: 2007 third-quarter and 9-month adjusted consolidated income
statements
Appendix 4: 2007 third-quarter and 9-month consolidated income statement
and reconciliation to adjusted consolidated income statement
Appendix 5: Trends in selected items in the adjusted income statement
Appendix 1: Explanatory Notes/Financial Indicators
Comparable net sales
When we refer to the change in our sales on a "comparable" basis, we mean that we exclude the impact of exchange rate movements and changes in Group structure (acquisitions and divestments of interests in entities and rights to products, and changes in consolidation method for consolidated entities).
We exclude the impact of exchange rates by recalculating sales for the prior period on the basis of exchange rates used in the current period. We exclude the impact of acquisitions by including sales from the acquired entity or product rights for a portion of the prior period equal to the portion of the current period during which we owned them, based on sales information we receive from the party from whom we make the acquisition.
Similarly, we exclude sales in the relevant portion of the prior period when we have sold an entity or rights to a product.
For a change
'/>"/>
| SOURCE sanofi-aventis Copyright©2007 PR Newswire. All rights reserved |